Find the latest clinical trials by condition, location & phase
Browse and search for drug information and related clinical trials
Explore a comprehensive list of organizations, including their profiles and details.
Latest updates on clinical trials, pharmaceuticals, and healthcare companies
Stay informed with timely notifications on clinical trials and research advancements.
No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
Akiram Therapeutics will present IND-enabling preclinical data on 177Lu-AKIR001, a targeted radiopharmaceutical, at the Targeted Radiopharmaceuticals Summit Europe 2024.
Akiram Therapeutics' 177Lu-AKIR001, a novel targeted radioimmunotherapy, has been approved to enter Phase 1 clinical trials.